The transcriptomic profile of ovarian cancer grading

被引:2
|
作者
Yao, Cindy Q. [1 ,2 ]
Francis Nguyen [1 ]
Haider, Syed [1 ,3 ]
Starmans, Maud H. W. [1 ,4 ]
Lambin, Philippe [4 ]
Boutros, Paul C. [1 ,2 ,5 ]
机构
[1] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[3] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England
[4] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol Maastro, Maastricht, Netherlands
[5] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
来源
CANCER MEDICINE | 2015年 / 4卷 / 01期
关键词
Grading; linear modeling; microarray; ovarian carcinoma; serous subtype; survival analysis; SEROUS CARCINOMA; GENE-EXPRESSION; STAGE; PROGNOSIS; PATTERNS; FEATURES; BEHAVIOR; SUBTYPES; SYSTEM;
D O I
10.1002/cam4.343
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian carcinoma is the leading cause of gynecological malignancy, with the serous subtype being the most commonly presented subtype. Recent studies have demonstrated that grade does not yield significant prognostic information, independent of TNM staging. As such, several different grading systems have been proposed to reveal morphological characteristics of these tumors, however each yield different results. To help address this issue, we performed a rigorous computational analysis to better understand the molecular differences that fundamentally explain the different grades and grading systems. mRNA abundance levels were analyzed across 334 total patients and their association with each grade and grading system were assessed. Few molecular differences were observed between grade 2 and 3 tumors when using the International Federation of Gynecology and Obstetrics (FIGO) grading system, suggesting their molecular similarity. In contrast, grading by the Silverberg system reveals that grades 1-3 are molecularly equidistant from one another across a spectrum. Additionally, we have identified a few candidate genes with good prognostic information that could potentially be used for classifying cases with similar morphological appearances.
引用
收藏
页码:56 / 64
页数:9
相关论文
共 50 条
  • [21] Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer
    Javellana, Melissa
    Eckert, Mark A.
    Heide, Janna
    Zawieracz, Katarzyna
    Weigert, Melanie
    Ashley, Sarah
    Stock, Elizabeth
    Chapel, David
    Huang, Lei
    Yamada, S. Diane
    Ahmed, Ahmed Ashour
    Lastra, Ricardo R.
    Chen, Mengjie
    Lengyel, Ernst
    CANCER RESEARCH, 2022, 82 (01) : 169 - 176
  • [22] Grading of ovarian carcinomas
    Mayr, D
    Diebold, J
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2000, 19 (04) : 348 - 353
  • [23] Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system
    Ishioka, S
    Sagae, S
    Terasawa, K
    Sugimura, M
    Nishioka, Y
    Tsukada, K
    Kudo, R
    GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 447 - 452
  • [24] Ovarian cancer specific kallikrein profile in effusions
    Shih, Le-Ming
    Salani, Ritu
    Fiegl, Michael
    Wang, Tian-Li
    Soosaipillai, Antoninus
    Marth, Christian
    Mueller-Holzner, Elisabeth
    Gastl, Gunther
    Zhang, Zhen
    Diamandis, Eleftherios P.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (02) : 501 - 507
  • [25] An integrated molecular profile of endometrioid ovarian cancer
    Pierson, William E.
    Peters, Pamela N.
    Chang, Matthew T.
    Chen, Lee-may
    Quigley, David A.
    Ashworth, Alan
    Chapman, Jocelyn S.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 55 - 61
  • [26] Profile of olaparib in the treatment of advanced ovarian cancer
    Chase, Dana M.
    Patel, Shreya
    Shields, Kristin
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2016, 8 : 125 - 129
  • [27] Global microRNA profile of primary ovarian cancer
    Chechlinska, M.
    Swiercz, A.
    Dansonka-Mieszkowska, A.
    Kulinczak, M.
    Zajdel, M.
    Rembiszewska, A.
    Kupryjanczyk, J.
    Siwicki, J. K.
    TUMOR BIOLOGY, 2012, 33 : 37 - 38
  • [28] Pharmacoeconomic profile of taxanes in advanced ovarian cancer
    Messori, A
    Trippoli, S
    ANTI-CANCER DRUGS, 1998, 9 (10) : 909 - 916
  • [29] HISTOLOGIC AND NUCLEAR GRADING AND STROMAL REACTIONS AS INDEXES FOR PROGNOSIS IN OVARIAN CANCER
    BARBER, HRK
    SOMMERS, SC
    SNYDER, R
    KWON, TH
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1975, 121 (06) : 795 - 807
  • [30] Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma
    Lee, Yu-Hsiang
    Kim, Jae Hoon
    Zhou, Hui
    Kim, Bo Wook
    Wong, David T.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (04): : 427 - 434